Guardian Wealth Advisors, LLC Amgen Inc Transaction History

Guardian Wealth Advisors, LLC

$838 Million
Q3 2024

A detailed history of Guardian Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Guardian Wealth Advisors, LLC holds 1,616 shares of AMGN stock, worth $475,104. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,616

Previous 1,651 2.12%

Holding current value

$475,104

Previous $515,000 0.97%

% of portfolio

0.06%

Previous 0.07%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $10,828 - $11,808	-35 Reduced 2.12%	1,616 $520,000
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $7,357 - $8,940	-28 Reduced 1.67%	1,651 $515,000
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $22,047 - $26,613	82 Added 5.13%	1,679 $477,000
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $4,346 - $4,903	17 Added 1.08%	1,597 $459,000
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $437 - $542	-2 Reduced 0.13%	1,580 $424,000
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $26,355 - $31,164	123 Added 8.43%	1,582 $351,000
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $27,997 - $34,124	-124 Reduced 7.83%	1,459 $352,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $12,120 - $13,670	54 Added 3.53%	1,583 $357,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $106,126 - $118,100	460 Added 43.03%	1,529 $372,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $32,232 - $35,657	-147 Reduced 12.09%	1,069 $258,000
Q4 2021 May 16, 2022	BUY	$198.88 - $227.6 $241,838 - $276,761	1,216 New	1,216 $274,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Wealth Advisors, LLC , based on Form 13F filings with the SEC.

News

Stay updated on Guardian Wealth Advisors, LLC with notifications on news.

Account

Guardian Wealth Advisors, LLC Amgen Inc Transaction History